REQUEST A DEMO
Total
USD $0.00
Search more companies

Magnum Medical SIA (Latvia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Magnum Medical SIA Profile Updated: December 24, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Russian Download a sample report

Magnum Medical SIA is based in Latvia, with the head office in Riga. The enterprise operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The enterprise was incorporated on February 18, 1992. There are currently 170 (estimated) people employed by Magnum Medical SIA. The company’s latest financial report indicates a net sales revenue increase of 7.73% in 2025. Its total assets grew by 7.78% over the same period. The enterprise’s net profit margin decreased by 0.13% in 2025.

Headquarters
Ulbrokas iela 23
Riga; Riga; Postal Code: 1021

Contact Details: Purchase the Magnum Medical SIA report to view the information.

Website: http://www.magnum.lv

Basic Information
Total Employees:
Purchase the Magnum Medical SIA report to view the information.
Registered Capital:
Purchase the Magnum Medical SIA report to view the information.
Financial Auditors:
Purchase the Magnum Medical SIA report to view the information.
Incorporation Date:
February 18, 1992
Key Executives
Purchase this report to view the information.
Chairman of the Supervisory Board
Purchase this report to view the information.
Member of Management Board
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Apotheka SIA
100%
Company Performance
Financial values in the chart are available after Magnum Medical SIA report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
7.73%
Total operating revenue
7.73%
Operating profit (EBIT)
2.27%
EBITDA
2.27%
Net Profit (Loss) for the Period
3.43%
Total Assets
7.78%
Total Equity
7.02%
Operating Profit Margin (ROS)
-0.17%
Net Profit Margin
-0.13%
Return on Equity (ROE)
-0.38%
Quick Ratio
0%
Cash Ratio
-0.03%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?